Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane Immune Effects in Breast Cancer
NCT02567929Completed
- Sponsor
- Konkuk University Medical Center
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol injection (veterinary) and sevoflurane in breast cancer (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Expression of CD39 and CD73 on circulating regulatory T cells. Started Mar 2016; status: completed.
02
Drugs
propofol injection (veterinary)sevoflurane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02567929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567929.